Bone mineral density in women with cytotoxic-induced ovarian failure

Clinical Endocrinology

Volumn 49, Issue 3, 1998, Pages 397-402

  Howell, S J ^a   Berger, G ^a   Adams, J E ^b   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMENORRHEA; ARTICLE; BONE DENSITY; BONE MINERAL; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; FEMUR NECK; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MALIGNANT NEOPLASTIC DISEASE; NONHODGKIN LYMPHOMA; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RADIUS; RETROSPECTIVE STUDY; SARCOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DENSITY; FEMALE; HODGKIN DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; OVARIAN FAILURE, PREMATURE; RETROSPECTIVE STUDIES; SARCOMA; STATISTICS, NONPARAMETRIC;

EID: 0031722229     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00550.x     Document Type: Article

References (31)

1. Bagur, D., Wittich, A., Ghiringhelli, G., Vega, E. & Mautalen, C. (1996) Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women. Medicina Buenas Aires, 56, 247-251.
2. Bruning, P.F., Pit, M.J., de-Jong Bakker, M., van den Ende, A., Hart, A. & van Enk, A. (1990) Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. British Journal of Cancer, 61, 308-310.
3. Castelo-Branco, C., Rovira, M., Pons, F., Duran, M., Siera, J., Vives, A., Balasch, J., Fortuny, A. & Vanrell, J. (1996) The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas, 23, 307-312.
4. Chapman, R.M., Sutcliffe, S.B. & Malpas, J.S. (1979) Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. Journal of the American Medical Association, 242, 1877-1881.
5. Clark, S.T., Radford, J.A., Crowther, D., Swindell, R. & Shalet, S.M. (1995) Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. Journal of Clinical Oncology, 13, 134-139.
6. Cummings, S.R., Black, D.M., Nevitt, M.C., Browner, W., Cauley, J., Ensrud, K., Genant, H.K., Palermo, L., Scott, J. & Vogt, T.M. (1993) Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet, 341, 72-75.
7. Davies, M.C., Hall, M.L. & Jacobs, H.S. (1990) Bone mineral loss in young women with amenorrhoea. British Medical Journal, 301, 790-793.
8. Davies, S.R., McCloud, P., Strauss. B.J. & Burger, H. (1995) Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas, 21, 227-236.
9. Doll, R. & Smith, P.G. (1986) The long-term effects of x irradiation in patients treated for metropathia haemorrhagica. British Journal of Radiology, 41, 362-368.
10. Drinkwater, B.L., Nilson, K., Chesnut, C.H. III., Bremner, W.J., Shainholtz, S. & Southworth, M.B. (1984) Bone mineral content of amenorrheic and eumenorrheic athletes. New England Journal of Medicine, 311, 277-281.
11. Fabbri, G., Petraglia, F., Segre, A., Maietta Latessa, A., Galassi, M.C., Cellini, M., Sardelli, S., Massolo, F., Genazzani, A. & Genazzani, A.R. (1991) Reduced spinal bone density in young women with amenorrhoea. European Journal of Obstetrics, Gynecology and Reproductive Biology, 41, 117-122.
12. Firooznia, H., Golimbu, C., Rafii, M. & Schwartz, M.S. (1986) Rate of spinal travecular bone loss in normal perimenopausal women: CT measurement. Radiology, 161, 735-738.
13. Hashimoto, K., Nozaki, M., Inoue, Y., Sano, M. & Nakano, H. (1995) The chronological change of vertebral bone loss following oophorectomy using dual energy X-ray absorptiometry: the correlation with specific markers of bone metabolism. Maturitas, 22, 185-191.
14. Kreuser, E.D., Felsenberg, D., Behles, C., Seibt-Jung, H., Mielcarek, M., Diehl, V., Dahmen, E. & Thiel, E. (1992) Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Annals of Oncology, 3(Suppl 4), 105-110.
15. Krølner, B. & Pors-Nielsen, S. (1982) Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies. Clinical Sciences, 62, 329-336.
16. Lees, B., Pugh, M., Siddle, N. & Stevenson, J.C. (1995) Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy. Osteoporosis International, 5, 344-348.
17. Looker, A.C., Wahner, H.W., Dunn, W.L., Calvo, M.S., Harris, T.B., Heyse, S.P., Johnston, C.C. Jr & Lindsay, R.L. (1995) Proximal femur bone mineral levels of US adults. Osteoporosis International, 5, 389-409.
18. Louis, O., Devroey, P., Kalender, W. & Osteaux, M. (1989) Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography. Fertility and Sterility, 52, 227-231.
19. Metka, M., Holzer, G., Heytmanek, G. & Huber, J. (1992) Hypergonadotropic hypogonadic amenorrhea (World Health Organization III) and osteoporosis. Fertility and Sterility, 57, 37-41.
20. Nilas, L. & Christiansen, C. (1987) Bone mass and its relationship to age and the menopause. Journal of Clinical Endocrinology and Metabolism, 65, 697-702.
21. Ratcliffe, M.A., Lanham, S.A., Reid, D.M. & Dawson, A.A. (1992) Bone mineral density (BMD) in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroids and premature menopause. Hematological Oncology, 10, 181-187.
22. Redman, J.R., Bajorunas, D.R., Wong, G., McDermott, K., Gnecco, C., Schneider, R., Lacher, M.J. & Lane, J.M. (1988) Bone mineralization in women following successful treatment of Hodgkin's disease. American Journal of Medicine, 85, 65-72.
23. Richelson, L.S., Wahner, H.W., Melton, L.J. III & Riggs, B.L. (1984) Relative contributions of aging and estrogen deficiency to post-menopausal bone loss. New England Journal of Medicine, 311, 1273-1275.
24. Saarto, T., Blomqvist, C., Ehnholm, C., Taskinen, M. & Elomaa, I. (1996) Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer. Journal of Clinical Endocrinology and Metabolism, 81, 4453-4457.
25. Savvas, M., Studd, J.W., Norman, S., Leather, A.T., Garnett, T.J. & Fogelman. I. (1992) Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. British Journal of Obstetrics and Gynaecology, 99, 757-760.
26. Schlechte, J., Walkner, L. & Kathol, M.A. (1992) Longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. Journal of Clinical Endocrinology and Metabolism, 75, 698-703.
27. Slemenda, C., Longcope, C., Peacock, M., Hui, S. & Johnston, C.C. (1996) Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. Journal of Clinical Investigation, 97, 14-21.
28. Stegman, M.R., Recker, R.R., Davies, K.M., Ryan, R.A. & Heaney, R.P. (1992) Fracture risk as determined by prospective and retrospective study designs. Osteoporosis International, 2, 290-297.
29. Sylven, L., Hagenfeldt, K. & Ringertz, H. (1995) Bone mineral density in middle-aged women with Turner's syndrome. European Journal of Endocrinology, 132, 47-52.
30. World Health Organization (1994) Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical report series 843. World Health Organisation, Geneva.
31. Yildiz, A., Sahin, L. Gol, K., Taner, Z., Uluturk, A. & Biberoglu, K. (1996) Bone loss rate in the lumbar spine: a comparison between natural and surgically induced menopause. International Journal of Gynaecology and Obstetrics, 55, 153-159.